INR 3188.0
(-1.61%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 159.02 Million | 244.94 Million | 42.76 Million | 221.76 Million | 214.08 Million | 408.39 Million |
Net Income | 90.37 Million | 324.46 Million | 390.46 Million | 171.62 Million | 372.16 Million | 402.07 Million |
Depreciation & Amortization | 63.62 Million | 59.78 Million | 51.02 Million | 45.34 Million | 44.09 Million | 52.52 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -5.41 Million | -38.65 Million | -245.37 Million | 113.49 Million | -71.98 Million | 137.93 Million |
Other non-cash items | 10.44 Million | -100.65 Million | -153.35 Million | -108.69 Million | -130.19 Million | -184.14 Million |
Investing Cash Flow | 248.52 Million | -45.48 Million | 23.83 Million | -274.49 Million | 157.43 Million | -364.3 Million |
Investments in PPE | -79.77 Million | -67.97 Million | -91.73 Million | -41.02 Million | -54.18 Million | -30.41 Million |
Acquisitions | 330 Thousand | 330 Thousand | 470 Thousand | 280 Thousand | -195.71 Million | 95.16 Million |
Investment purchases | -276.18 Million | -12.69 Million | - | -270.65 Million | - | -567.74 Million |
Sales/Maturities of investments | 604.14 Million | 5.94 Million | 80.16 Million | - | 359.96 Million | 103.74 Million |
Other Investing Activities | 28.29 Million | 28.91 Million | 34.93 Million | 36.9 Million | 47.35 Million | 34.94 Million |
Financing Cash Flow | -425.96 Million | -119.02 Million | -45.94 Million | -124.4 Million | -138.88 Million | -92.89 Million |
Debt repayment | - | - | - | - | - | - |
Dividends payments | -425.96 Million | -119.02 Million | -45.94 Million | -124.4 Million | -136.96 Million | -90.62 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -880 Thousand | - | - | - | -25.53 Million | -17.72 Million |
Accounts receivables | -78.73 Million | 76.85 Million | -70.43 Million | 64.26 Million | -34.71 Million | 64.86 Million |
Accounts payables | 48.2 Million | 75.09 Million | -47.56 Million | -14.24 Million | 24.53 Million | -35.5 Million |
Inventory | -9.99 Million | -181.01 Million | -83.43 Million | 20.78 Million | -89.25 Million | 73.21 Million |
Other working capital | 35.11 Million | -9.58 Million | -43.95 Million | 42.69 Million | 27.45 Million | 35.36 Million |
Cash at beginning of period | 255.88 Million | 157.08 Million | 136.43 Million | 313.56 Million | 80.93 Million | 129.73 Million |
Cash at end of period | 340.53 Million | 237.52 Million | 157.08 Million | 136.43 Million | 313.56 Million | 80.92 Million |
Capital Expenditure | -79.77 Million | -67.97 Million | -91.73 Million | -41.02 Million | -54.18 Million | -30.41 Million |
Effect of forex changes on cash | 103.07 Million | - | - | - | - | - |
Net cash flow / Change in cash | 84.65 Million | 80.44 Million | 20.65 Million | -177.13 Million | 232.63 Million | -48.8 Million |
Free Cash Flow | 79.25 Million | 176.97 Million | -48.97 Million | 180.74 Million | 159.9 Million | 377.97 Million |
Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 90.37 Million | 40.06 Million | 5.68 Million | 20.16 Million | 24.47 Million | 16.64 Million |
Depreciation & Amortization | 63.62 Million | 18.91 Million | 14.88 Million | 14.77 Million | 15.06 Million | 14.99 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -5.41 Million | - | - | - | - | - |
Other non-cash items | 10.44 Million | -21.15 Million | -14.88 Million | -14.77 Million | -15.06 Million | -14.99 Million |
Investing Cash Flow | 248.52 Million | - | - | - | - | - |
Investments in PPE | -79.77 Million | - | - | - | - | - |
Acquisitions | 330 Thousand | - | - | - | - | - |
Investment purchases | -276.18 Million | - | - | - | - | - |
Sales/Maturities of investments | 604.14 Million | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | -425.96 Million | - | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | -425.96 Million | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | -78.73 Million | - | - | - | - | - |
Accounts payables | 48.2 Million | - | - | - | - | - |
Inventory | -9.99 Million | - | - | - | - | - |
Other working capital | 35.11 Million | - | - | - | - | - |
Cash at beginning of period | 255.88 Million | 302.71 Million | 403.35 Million | 383.19 Million | 255.88 Million | 239.24 Million |
Cash at end of period | 340.53 Million | 340.53 Million | 5.68 Million | 403.35 Million | 24.47 Million | 255.88 Million |
Capital Expenditure | -79.77 Million | - | - | - | - | - |
Effect of forex changes on cash | 103.07 Million | - | - | - | - | - |
Net cash flow / Change in cash | 84.65 Million | 37.82 Million | -397.67 Million | 20.16 Million | -231.41 Million | 16.64 Million |
Free Cash Flow | 79.25 Million | 37.82 Million | 5.68 Million | 20.16 Million | 24.47 Million | 16.64 Million |
ARBB
GRN
SHINEFASH
FDA
ESCORP
5512